[New therapeutic possibilities in chronic ITP in adults].
Jönsson
Sofia
S
Sektionen för hematologi, Sahlgrenska universitetssjukhuset/ Sahlgrenska, Göteborg. sofia.jonsson@vgregion.se
Olsson
Bob
B
Wadenvik
Hans
H
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001565:Benzoates / Q000008:administration & dosage; D002352:Carrier Proteins / Q000008:administration & dosage; D002908:Chronic Disease; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage; D017713:Platelet Transfusion; D011239:Prednisolone / Q000008:administration & dosage; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D011720:Pyrazoles / Q000008:administration & dosage; D011961:Receptors, Fc / Q000008:administration & dosage; D053628:Receptors, Thrombopoietin / Q000187:drug effects; D011993:Recombinant Fusion Proteins; D013156:Splenectomy; D013926:Thrombopoietin
D000970:Antineoplastic Agents; D001565:Benzoates; D002352:Carrier Proteins; D005938:Glucocorticoids; D006834:Hydrazines; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; D011239:Prednisolone; C488777:romiplostim; C520809:eltrombopag